When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research
Neuroethics November 6, 2023 Edward Jacobs, Ashleigh Murphy-Beiner, Ian Rouiller et al. 23 citations
Abstract The ethical value—and to some scholars, necessity—of providing trial patients with post-trial access (PTA) to an investigational drug has been subject to significant attention in the field of research ethics. Although no consensus has emerged, it seems clear that, in some trial contexts, various factors make PTA particularly appropriate. We outline the atypical aspects of psychedelic...